A family’s lawsuit against Insys Therapeutics involving a woman’s fatal overdose on the opioid Subsys is resuming in New Jersey following Thursday’s racketeering conviction of the company’s founder and four other executives in a separate case.

Founder and former chief executive John Kapoor and four other Insys executives were found guilty of charges that they made payouts to doctors who prescribed their products and misled insurance companies about whether patients needed the drugs. The convictions, following a 10-week federal trial in Boston, marked the first successful prosecution of top pharmaceutical executives for crimes related to the illicit marketing and prescribing of opioids.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]